According to Cognitive Market Research, the global Tranexamic Acid market size was USD 86.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 34.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 25.98 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 19.92 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 4.33 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 1.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
The USP25 category is the fastest growing segment of the Tranexamic Acid industry
